
Treatment that begins with an assessment.
The face is read as a whole rather than area by area, the plan is written down before anything is injected, the first treatment is conservative by design, and the result is judged at a review two weeks later.
A non-surgical aesthetic practice in London, organised around the assessment rather than the treatment menu. Laxity, lost volume, movement and skin quality are four separate problems, and only one of them responds to any given syringe. So the finding decides the treatment, and the face is planned as a whole rather than one area at a time.
In practice that means being told plainly when an injectable will not solve what is bothering you, when one area should be treated rather than three, and when the correct answer is to do nothing for now. A first treatment is deliberately light. It is far easier to add at review than to dissolve or wait out an overfilled result.
Every treatment is set out in full before anyone consents to it, including the complications that need a written protocol and the circumstances in which it is the wrong choice. What the consultation involves.
Each page sets out what the treatment changes, what it cannot change, who should decline it, how much it costs in London and what moves that number, how long it lasts, recovery and aftercare.
Where the finding is movement or lost volume. Each is planned from an assessment of the whole face rather than from the area you point to.

Treatment
A prescription-only medicine. The difficult part is not the injection, it is the dose.
Read
Treatment
A medical device, not a medicine. That single fact explains most of what is wrong with the market.
Read
Treatment
The most requested treatment in Britain, and the one where technique shows fastest.
ReadWhere the frame has changed rather than the surface. Structure is restored before contour, and a first treatment is deliberately light.

Treatment
The highest-leverage area on the face, and the easiest one to ruin by degrees.
Read
Treatment
Definition comes from proportion. Frequently the chin is the answer, not the jaw.
Read
Treatment
Small volumes, thin skin, high stakes. The area where patient selection matters most.
ReadWhere the envelope rather than the structure is the problem. These work over a course and are judged months after the last session.

Treatment
Not a filler. A skin quality treatment that happens to be delivered by injection.
Read
Treatment
Hydration delivered into the skin rather than onto it. A course, not an appointment.
Read
Treatment
A newer category with real promise and marketing that has already outrun the evidence.
ReadWhere the finding is a discrete pocket of fat, or a medical problem with an aesthetic route to treating it.
Almost every disappointing result in this field is a well performed treatment aimed at the wrong finding. Laxity, lost volume, movement and skin quality look alike in a mirror and respond to entirely different things. These pages set out what each finding is, how it is assessed, what treats it in London and what will not.
Hollowing at the temple and midface, and the flattening that follows it.
ReadMovement lines, etched lines, and the crepe that is neither of them.
ReadFour different causes look identical in a mirror. Only one responds to filler.
ReadBorder, proportion and shape, which are separate problems from volume.
ReadDefinition, jowling and heaviness, and where non-surgical treatment stops.
ReadThe envelope rather than the structure, and where its limits are.
ReadDullness, dehydration and a barrier that is not doing its job.
ReadNo badges, because a badge tells you almost nothing. The framework, and what it means for you, tells you a great deal.
Botulinum toxin is a prescription-only medicine. It must be prescribed for you individually by a qualified prescriber who has assessed you in person, and under the Human Medicines Regulations 2012 it may not be advertised to the public. That is why there is no price list here and no toxin brand named beside a figure.
Dermal fillers are not medicines. They are regulated as medical devices, which means there is no prescription requirement and, at present, no general licence needed to inject them in England. Legislation enabling a licensing scheme exists but has not been brought into force. Where a clinic is registered with the Care Quality Commission, that registration covers defined regulated activities rather than every procedure on the menu.
Equipment and product matter less than the decision to use them. Products are chosen for the finding rather than because a representative visited, batch and lot are recorded, and standardised photographs are taken in consistent light for comparison rather than for advertising.
So the safeguard is what a practice commits to and what you can verify: assessment before treatment, prescribing only after seeing you, a written plan, conservative first doses, hyaluronidase held on site with a protocol for using it, an out-of-hours route to a clinician, and a review included rather than charged for.
A consultation that runs for ten minutes and ends with a price is not an assessment. This is the ground a proper one covers before treatment is discussed at all.
The same order every time. No prescribing without a face-to-face assessment, and no consent taken in the same breath as the plan.
Tell us the area that concerns you and what you have tried. You are told which treatments are relevant, which are not, and what an assessment would need to establish.
A full facial assessment, a complete medical history and a discussion of what is realistic. Where a prescription-only medicine is involved, this must be face to face with the prescriber.
Areas, sequence, product, quantity and cost, set out in writing with the risks that need a protocol. You take it away and think about it.
Two-stage consent, with a cooling-off period rather than a signature in the same appointment as the plan. The first treatment is conservative by design.
The result is judged once swelling has settled. Adjustment, where it is needed, happens here rather than being sold as a second course.
Written aftercare, a route to reach a clinician out of hours, and a plan for when the effect wears off rather than an assumption that you rebook.
There is no price list on this site, and the reason is not evasion. What it costs to treat a face is driven by how many areas need addressing, how much product that takes and which product class is appropriate, and none of that can be known before the face has been assessed. A figure quoted before an assessment is a guess with a decimal point.
What you should expect instead is a written quotation after the assessment, stating the areas, the product, the quantity, what is included and what is not, and whether the review and any adjustment at it are covered. That document is what you compare between London clinics, rather than a headline per-area price.
Prescription-only medicines are a separate matter. They may not lawfully be advertised to the public, so a clinic publishing a named toxin brand with a price attached is telling you something about how it reads the rules. What treatment costs in London.
Enquiries come from every part of the city and from well beyond it. Consultations are arranged by appointment, so the practical question is how far you are willing to travel for an assessment rather than which street a door sits on.
Marylebone, Fitzrovia, Mayfair, Soho, Belgravia and the Harley Street medical district.
Chelsea, South Kensington, Knightsbridge, Notting Hill, Holland Park and Fulham.
Hampstead, St John's Wood, Primrose Hill, Islington, Highgate and Muswell Hill.
The City, Clerkenwell, Shoreditch, Canary Wharf, Wimbledon, Richmond and Clapham.
That is the premise here. Nothing is offered before a full facial assessment and a complete medical history, and where a prescription-only medicine is involved the prescriber must see you in person before anything is dispensed. A consultation that reaches a price in ten minutes has skipped the part that decides the result.
The range across London is wider than anywhere else in the country. Cost depends on how many areas are treated, how much product that takes and which product class is appropriate, which is why a written quotation follows the assessment. Prescription-only medicines are not priced in public, which is a legal constraint rather than a preference.
Yes, and for any treatment involving a prescription-only medicine the prescriber must assess you face to face. Even where that does not apply, a first treatment planned from an assessment is more conservative, cheaper over time and easier to adjust than one planned from a menu.
Enquiries come from across the city, including Marylebone and the Harley Street medical district, Mayfair and Fitzrovia, Chelsea, Kensington and Knightsbridge, Hampstead and Islington, the City and Clerkenwell, and Wimbledon and Richmond. Consultations are arranged by appointment.
It depends entirely on the treatment. Botulinum toxin appears over several days and is settled at about two weeks. Filler is visible immediately but should be judged at two weeks once swelling has gone. Bio-remodelling and regenerative injectables are assessed three to six months after a course.
Every treatment described here carries risk, and the risk is managed by assessment, technique and preparation rather than by reassurance. What separates clinics is whether a written complications protocol exists, whether hyaluronidase is held on the premises, and whether there is a route to reach a clinician out of hours.
Tell us the area that concerns you, what you have had done before and what you would like changed. You will get a considered reply setting out which treatments apply, which do not, and what an assessment would need to establish first.
hello@aestheticlaunchlab.comPlease do not send clinical photographs or medical records by email. If something has gone wrong after a procedure, contact the practitioner who treated you, or NHS 111, rather than waiting for a reply here.